Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1306763
Name of medicinal product: ATRIANCE
Active substances:
Nelarabine
Estonian, English, Latin
ATC code: L01BB07
Dosage form: solution for infusion
Route of administration: intravenous use
Strengh: 5mg 1ml
Amount in package: 50ml 6TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Nelarabine is indicated for the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. Due to the small patient populations in these disease settings, the information to support these indications is based on limited data.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: January 13, 2020
: This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Patients and healthcare professionals are asked to report any suspected adverse reactions to State Agency of Medicines.State Agency of Medicines
Marketing authorization holder: Sandoz Pharmaceuticals d.d. 
Marketing authorization number: EU/1/07/403 
Marketing authorization issued on: August 22, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: January 30, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere